The novel protocol allows proteins over 100 amino acids long to be synthesised in hours and include amino acids that do not occur in the human proteome.
List view / Grid view
Filter the results
Two studies reveal the importance of timing in Huntington’s disease interventions and demonstrate interleukin-6 may play a protective role.
Researchers who developed modified proteins say this could be used in the fight against COVID-19, by tackling cytokine storms.
Researchers at MIT have developed a mathematical model that can calculate whether diabetes treatments in pre-clinical trials will be successful in humans.
A new antibiotic compound has been identified by researchers who designed a machine-learning algorithm to screen millions of molecules.
Researchers have conducted a genetic screen in mice to discover a family of genes that contributes to the development of Huntington's.
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
A new platform combines AI, flow chemistry and robotics to minimise the need for human intervention in the synthesis process.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
A study has detailed the change in the gut microbiome, increasing the potential for new IBD therapies.
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumour or another disease site.
A method of imaging calcium activity that is based on magnetic resonance imaging (MRI) could help to image deep within the brain...
Researchers have designed a drug delivery capsule that can stay in the stomach for up to 1 month, and could sense and treat infections...